Antonenko, S., & Telegeev, G. (2023). Inhibition of USP1, a new partner of Bcr-Abl, results in decrease of Bcr-Abl level in K562 cells. Experimental Oncology, 42(2), 109–114. https://doi.org/10.32471/exp-oncology.2312-8852.vol-42-no-2.14533